Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease
暂无分享,去创建一个
R. Virmani | F. Otsuka | F. Kolodgie | Songwen Zhang | M. Krieger | D. Mani | R. Liao | Jonathan D. Smith | D. Haagensen | Jianru Shi | J. Guan | K. Tsukamoto | W. Weng
[1] Valentin Gogonea,et al. Function and Distribution of Apolipoprotein A1 in the Artery Wall Are Markedly Distinct From Those in Plasma , 2013, Circulation.
[2] A. von Eckardstein,et al. Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease: Role of High-Density Lipoprotein–Proteome Remodeling , 2013, Circulation.
[3] Songwen Zhang,et al. Dietary Manipulation and Social Isolation Alter Disease Progression in a Murine Model of Coronary Heart Disease , 2012, PloS one.
[4] B. Garner,et al. Molecular Dynamics Analysis of Apolipoprotein-D - Lipid Hydroperoxide Interactions: Mechanism for Selective Oxidation of Met-93 , 2012, PloS one.
[5] W. Kim,et al. Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: implications for lipid antioxidant activity and Alzheimer's disease. , 2012, The Biochemical journal.
[6] I. Cózar-Castellano,et al. Genetic deficiency of apolipoprotein D in the mouse is associated with nonfasting hypertriglyceridemia and hyperinsulinemia. , 2011, Metabolism: clinical and experimental.
[7] A. Schmidtchen,et al. Up-Regulation of A1M/α1-Microglobulin in Skin by Heme and Reactive Oxygen Species Gives Protection from Oxidative Damage , 2011, PloS one.
[8] D. Sanchez,et al. Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquat‐challenged dopaminergic systems , 2011, Glia.
[9] Y. Kuwahara,et al. Neutrophil gelatinase-associated lipocalin: A new antioxidant that exerts its cytoprotective effect independent on Heme Oxygenase-1 , 2011, Free radical research.
[10] Beñat Mallavia,et al. Animal Models of Cardiovascular Diseases , 2011, Journal of biomedicine & biotechnology.
[11] Shicui Zhang,et al. Antioxidant activities of recombinant amphioxus (Branchiostoma belcheri) apolipoprotein D , 2011, Molecular Biology Reports.
[12] F. Toledo,et al. A role of apolipoprotein D in triglyceride metabolism[S] , 2010, Journal of Lipid Research.
[13] G. Couper,et al. Defective DNA Replication Impairs Mitochondrial Biogenesis In Human Failing Hearts , 2010, Circulation research.
[14] E. Rassart,et al. ApoD, a glia‐derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury , 2010, Glia.
[15] D. Walker,et al. Apolipoprotein D: An overview of its role in aging and age-related diseases , 2010, Cell cycle.
[16] G. Perdomo,et al. Apolipoprotein D in Lipid Metabolism and Its Functional Implication in Atherosclerosis and Aging , 2008, Aging.
[17] S. Xue,et al. Osteopontin protects against cardiac ischemia-reperfusion injury through late preconditioning , 2009, Heart and Vessels.
[18] E. Rassart,et al. Neuroprotective Effect of Apolipoprotein D against Human Coronavirus OC43-Induced Encephalitis in Mice , 2008, The Journal of Neuroscience.
[19] Y. Sasaguri,et al. Spontaneous Myocardial Infarction in Mice Lacking All Nitric Oxide Synthase Isoforms , 2008, Circulation.
[20] M. Bastiani,et al. Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress , 2008, Aging cell.
[21] G. Franceschini,et al. Anti-Inflammatory and Cardioprotective Activities of Synthetic High-Density Lipoprotein Containing Apolipoprotein A-I Mimetic Peptides , 2008, Journal of Pharmacology and Experimental Therapeutics.
[22] H. Zhang,et al. Apolipoprotein D as a novel marker in human end-stage heart failure: a preliminary study , 2008, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[23] M. Birnbaum,et al. Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. , 2007, Cell metabolism.
[24] A. Skerra,et al. Structural Insight into the Dual Ligand Specificity and Mode of High Density Lipoprotein Association of Apolipoprotein D*♦ , 2007, Journal of Biological Chemistry.
[25] Colin W. Rundel,et al. Overexpression of a Drosophila Homolog of Apolipoprotein D Leads to Increased Stress Resistance and Extended Lifespan , 2006, Current Biology.
[26] Songwen Zhang,et al. Diet-Induced Occlusive Coronary Atherosclerosis, Myocardial Infarction, Cardiac Dysfunction, and Premature Death in Scavenger Receptor Class B Type I-Deficient, Hypomorphic Apolipoprotein ER61 Mice , 2005, Circulation.
[27] M. Krieger,et al. Lymphocytes Are Not Required for the Rapid Onset of Coronary Heart Disease in Scavenger Receptor Class B Type I/Apolipoprotein E Double Knockout Mice , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[28] S. Wells,et al. Immunologic and steroid binding properties of the GCDFP-24 protein isolated from human breast gross cystic disease fluid , 1990, Breast Cancer Research and Treatment.
[29] H. Iwao,et al. Angiotensin blockade inhibits osteopontin expression in non-infarcted myocardium after myocardial infarction. , 2005, Journal of pharmacological sciences.
[30] E. Rassart,et al. Apolipoprotein D and Platelet-Derived Growth Factor-BB Synergism Mediates Vascular Smooth Muscle Cell Migration , 2004, Circulation research.
[31] D. Dichek,et al. Macrophage-Targeted Overexpression of Urokinase Causes Accelerated Atherosclerosis, Coronary Artery Occlusions, and Premature Death , 2004, Circulation.
[32] Qing Nie,et al. Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. , 2004, Physiological genomics.
[33] Y. Shiratori,et al. Spatially and temporally different expression of osteonectin and osteopontin in the infarct zone of experimentally induced myocardial infarction in rats. , 2003, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[34] A. Rigotti,et al. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. , 2003, Endocrine reviews.
[35] N. Andrews,et al. Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] M. Krieger,et al. Loss of SR-BI Expression Leads to the Early Onset of Occlusive Atherosclerotic Coronary Artery Disease, Spontaneous Myocardial Infarctions, Severe Cardiac Dysfunction, and Premature Death in Apolipoprotein E-Deficient Mice , 2002, Circulation research.
[37] Zhonglin Xie,et al. Exaggerated Left Ventricular Dilation and Reduced Collagen Deposition After Myocardial Infarction in Mice Lacking Osteopontin , 2001, Circulation research.
[38] D. Sawyer,et al. Cell Therapy Attenuates Deleterious Ventricular Remodeling and Improves Cardiac Performance After Myocardial Infarction , 2001, Circulation.
[39] A. Rigotti,et al. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[40] P. Thorén,et al. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[41] C. Rice-Evans,et al. Factors influencing the antioxidant activity determined by the ABTS.+ radical cation assay. , 1997, Free radical research.
[42] J. Simard,et al. Interleukin‐6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin‐1α on apolipoprotein D and GCDFP‐15 expression in human breast cancer cells , 1995, International journal of cancer.
[43] D. Horsfall,et al. Differential expression of apolipoprotein-D and prostate specific antigen in benign and malignant prostate tissues. , 1995, The Journal of urology.
[44] J. M. Morais Cabral,et al. Arachidonic acid binds to apolipoprotein D: implications for the protein's function , 1995, FEBS letters.
[45] S M Schwartz,et al. Macrophages express osteopontin during repair of myocardial necrosis. , 1994, The American journal of pathology.
[46] R. Hammer,et al. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. , 1993, The Journal of clinical investigation.
[47] N. Maeda,et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.
[48] E. Rubin,et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.
[49] J. Gueriguian,et al. A specific progesterone-binding component of human breast cyst fluid. , 1973, The Journal of biological chemistry.